라이트닝 바카라 사이트 opens Branchburg manufacturing facility in the U.S., strengthening global production footprint

[by Kang, In Hyo] Celltrion held an opening ceremony on January 5 (local time) at its manufacturing facility in Branchburg, New Jersey, formally inaugurating a strategic U.S. production hub aimed at strengthening the company’s global biopharmaceutical manufacturing capacity.

The ceremony represented Celltrion's first official event following the completion of its acquisition of the Branchburg facility in late 2025, marking the full-scale launch of the site as a central hub in the company’s global production network.

The event was attended by a range of local and national dignitaries, including U.S. Senator Andy Kim of New Jersey, U.S. Representative Thomas Kean Jr., and Branchburg Township Mayor Thomas Young, alongside senior executives from Celltrion. The attendees collectively commemorated the official launch of Celltrion's U.S. manufacturing base. During the event, Representative Kean drew particular attention by presenting an American flag that he had personally brought, remarking, "I hope you'll hang it at the plant," a gesture that was met with strong applause from those in attendance.

At the opening ceremony, Seo Jung-jin, Chairman of the Celltrion Group, who was present in person, underscored the strategic importance of the Branchburg facility in the group's global business framework. In his welcoming address, he stated, "We intend to develop the Branchburg site into an integrated contract development and manufacturing organization (CDMO) production base, including a research center, which, together with our headquarters in Songdo, Korea, will constitute a central pillar supporting Celltrion's global growth." During the event, Seo also formally appointed Todd Winge as CEO of Celltrion Branchburg LLC, marking the official establishment of a localized management system for the U.S. operation.

With the inauguration of the Branchburg facility, 라이트닝 바카라 사이트 has proactively mitigated tariff risks and established a stable production and supply infrastructure in the United States, thereby further reinforcing its global production network. Notably, by acquiring a current Good Manufacturing Practice (cGMP)-compliant facility previously operated by the multinational pharmaceutical company Eli Lilly and Company, 라이트닝 바카라 사이트 minimized opportunity costs and execution risks typically associated with securing a greenfield site, while accelerating the pace of its global business expansion. In addition, the company has finalized a contract manufacturing organization (CMO) agreement with Eli Lilly for the production of bioactive drug substances (DS) and secured the retention of skilled local personnel, ensuring seamless production continuity and immediate operational stability following the acquisition.

Going forward, 라이트닝 바카라 사이트 plans to leverage the Branchburg facility as a strategic manufacturing hub for products destined for the U.S. market, while concurrently expanding its CMO and CDMO services for global pharmaceutical partners. In addition, the company aims to strengthen its overall business structure by integrating localized U.S. production capabilities with its direct sales system and continuously creating new business opportunities.

"The inauguration of the Branchburg facility represents more than the establishment of a manufacturing base in the United States, it constitutes an important turning point in enhancing our global production and supply infrastructure. By effectively eliminating tariff risks through localized manufacturing and enhancing the competitiveness of our global CDMO operations, we aim to advance decisively toward our objective of becoming a global big pharma," a Celltrion official said.